Literature DB >> 31593218

Pattern recognition on fluorodeoxyglucose positron emission tomography/computed tomography in infective endocarditis: within the normal limits?

Paola A Erba1,2, Riemer H J A Slart2,3.   

Abstract

Entities:  

Year:  2020        PMID: 31593218      PMCID: PMC7029765          DOI: 10.1093/ehjci/jez254

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


× No keyword cloud information.
This editorial refers to ‘Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [ During the last years, multimodality molecular imaging has been progressively increased the clinical indication in cardiovascular disease, moving from the historical horizon of coronary artery disease into the arena of cardiovascular infection and inflammation. Technical developments have been relatively fast and resulted into a new-concept development widened the scope of what imaging as a single technology can enable in terms of patients’ management. The introduction of positron emission computed tomography with 18F-fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) in the clinical work-up of patients with infective endocarditis (IE) represents a successful story based on the integration of image data across different modalities and fusion of the available information. [18F]FDG PET/CT has shown to significantly improved the diagnostic yield in the prosthetic valve endocarditis (PVE). Consequently, the [18F]FDG PET/CT has been incorporated in the diagnostic algorithm of PVE in the latest European Society of Cardiology (ESC) Guidelines for the management of IE. Whole-body [18F]FDG PET/CT has also emerged as an excellent tool in the detection of septic embolism or metastatic infections, in the management of cardiovascular implantable electronic device infection and, finally for prognostic assessment in IE. However, interpretation of [18F]FDG PET/CT findings with regard to what is to be considered normal and knowledge of the potential confounders is not yet fully established. From the application in daily routine, it has become clear that [18F]FDG PET/CT findings should always be correlated to clinical and other diagnostic findings and, as also recommended in the ESC guidelines need a discussion in a multidisciplinary ‘Endocarditis Team’., Indeed, the proper interpretation of [18F]FDG PET/CT findings requires profound knowledge of the patients clinical situation, which include the microbiological results and the ongoing anti-microbiotic treatment(s), the ‘valve’surgical history, starting from the time of the first surgical procedure to the subsequent procedures, including the used materials and potential surgical-related complications, factors that all significantly may affect the intensity of [18F]FDG uptake. For the latter, the ESC Guidelines suggest delaying PET/computed tomography angiography (CTA) until 3 months after surgery. However, one recent study suggests that when appropriate criteria of imaging interpretation are applied, the number of false-positive scans performed early after surgery is very low. Literature is very scarce on data on [18F]FDG uptake pattern in non-infected prosthetic valves. Roque et al. published in this issue reinforce our understanding of the concept of normal finding on [18F]FDG PET. In this study, they prospectively evaluated patients without suspected infection who underwent serial cardiac PET/CTA examinations at 1, 6, and 12 months after surgery. The [18F]FDG uptake distribution pattern and anatomic changes were evaluated. Their results show no significant differences in [18F]FDG distribution or uptake values between 1, 6, or 12 months. No abnormal anatomic changes or endocarditis lesions were detected in any patient during follow-up, meaning that the recommended 3-month safety period could maybe be reconsidered to be shortened, in which [18F]FDG PET findings are assigned as ‘within the normal limits’. The demonstration of a typical pattern of [18F]FDG uptake in (recently) implanted normal Prosthetic valves, as result of post-operative inflammation represents a step towards a more harmonized and standardized image interpretations., From a pathophysiology perspective, it is extremely common feature of every early post-operative setting, yet not unsurprising that such uptake occurred in early surgical valve implants. However, [18F]FDG uptake in inflammatory cells is just one of the (several) potential pitfalls (see Table ). Despite obtained in a relatively small number of patients and decontextualized from any clinical setting, these results have the power to reinforce the need for continued engagement for unsolved issues to transform PET/CT image interpretation in IE from a purely qualitative task to one that is reproducible and into clinically meaningful outcomes. In fact, while we still have to solve technical challenges to harmonize and standardize image acquisition protocols, quantification approaches, and reporting/scoring systems, we also have to work to improve the available PET/CT for a vast majority of patients. This also includes quick access to PET/CT procedures, availability also for critical patients, quick decision-making through comprehensive multimodality imaging and clinical data integration, with the ultimate goal of modify the unacceptable high mortality of patients with IE. Procedural pitfalls and recommendations of FDG PET/CT imaging in infective endocarditis (IE) and cardiac implantable electronic device (CIED) infection • Duration procedure • Recent valve implantation • Surgical adhesives • Complications • Excluding non-infectious causes • Proper use of the combined CT • Learning curve • Motion artefacts • Metal artefacts (CIED, dense PHV) and over-correction due to beam hardening • Mismatch PET and CT fusion • Isolated, small, or mobile vegetations due to limited temporal and spatial resolution • NVP Conflict of interest: none declared.
Table 1

Procedural pitfalls and recommendations of FDG PET/CT imaging in infective endocarditis (IE) and cardiac implantable electronic device (CIED) infection

FDG PET/CT in IE and CIED infection
Confounding factorsPitfallsRecommendations
False positiveSurgical procedure

• Duration procedure

• Recent valve implantation

• Surgical adhesives

• Complications

• Information procedure needed
Pathological conditions• Lipomatous hypertrophy of the interatrial septum, thrombi, vasculitis, tumour metastases, atherosclerotic plaques, and marantic IE

• Excluding non-infectious causes

• Proper use of the combined CT

• Learning curve


False positive or false negativePatient preparation• Physiological myocardial uptake: false positive or negative (masked)• Optimal procedural preparation: fasting and low-carbohydrate diet (±heparin i.v.)
PET technical procedure

• Motion artefacts

• Metal artefacts (CIED, dense PHV) and over-correction due to beam hardening

• Mismatch PET and CT fusion

• Proper quality check images
PET imaging reading• No standardized qualitative and quantitative scoring method• Standard procedures (EANM), reproducibility warranted

False negativePET imaging reading

• Isolated, small, or mobile vegetations due to limited temporal and spatial resolution

• NVP

• Need for a multimodality approach in which each imaging modality covers the other’s possible shortcomings
  11 in total

1.  Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center.

Authors:  María N Pizzi; Albert Roque; Nuria Fernández-Hidalgo; Hug Cuéllar-Calabria; Ignacio Ferreira-González; María T Gonzàlez-Alujas; Gerard Oristrell; Laura Gracia-Sánchez; Juan J González; José Rodríguez-Palomares; Manuel Galiñanes; Olga Maisterra-Santos; David Garcia-Dorado; Joan Castell-Conesa; Benito Almirante; Santiago Aguadé-Bruix; Pilar Tornos
Journal:  Circulation       Date:  2015-08-14       Impact factor: 29.690

2.  The round table approach in infective endocarditis & cardiovascular implantable electronic devices infections: make your e-Team come true.

Authors:  Paola A Erba; Gilbert Habib; Andor W J M Glaudemans; Jose M Miro; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07       Impact factor: 9.236

3.  Recommendations on nuclear and multimodality imaging in IE and CIED infections.

Authors:  Paola Anna Erba; Patrizio Lancellotti; Isidre Vilacosta; Oliver Gaemperli; Francois Rouzet; Marcus Hacker; Alberto Signore; Riemer H J A Slart; Gilbert Habib
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-24       Impact factor: 9.236

Review 4.  Diagnostic value of imaging in infective endocarditis: a systematic review.

Authors:  Anna Gomes; Andor W J M Glaudemans; Daan J Touw; Joost P van Melle; Tineke P Willems; Alexander H Maass; Ehsan Natour; Niek H J Prakken; Ronald J H Borra; Peter Paul van Geel; Riemer H J A Slart; Sander van Assen; Bhanu Sinha
Journal:  Lancet Infect Dis       Date:  2016-10-18       Impact factor: 25.071

Review 5.  18F-fluorodeoxyglucose positron emission/computed tomography and computed tomography angiography in prosthetic heart valve endocarditis: from guidelines to clinical practice.

Authors:  Laurens E Swart; Asbjørn M Scholtens; Wilco Tanis; Koen Nieman; Ad J J C Bogers; Fred J Verzijlbergen; Gabriel P Krestin; Jolien W Roos-Hesselink; Ricardo P J Budde
Journal:  Eur Heart J       Date:  2018-11-01       Impact factor: 29.983

6.  Prognostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Infective Endocarditis.

Authors:  Sovannarith San; Eleonore Ravis; Laetitia Tessonier; Mary Philip; Serge Cammilleri; Flora Lavagna; Giulia Norscini; Florent Arregle; Hélène Martel; Leopold Oliver; Olivier Torras; Sébastien Renard; Pierre Ambrosi; Laurence Camoin; Anne Claire Casalta; Sandrine Hubert; Jean Paul Casalta; Frédérique Gouriet; Alberto Riberi; Jean-François Avierinos; Hubert Lepidi; Frederic Collart; Didier Raoult; Michel Drancourt; Gilbert Habib
Journal:  J Am Coll Cardiol       Date:  2019-08-27       Impact factor: 24.094

7.  Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion.

Authors:  Ludivine Saby; Olivia Laas; Gilbert Habib; Serge Cammilleri; Julien Mancini; Laetitia Tessonnier; Jean-Paul Casalta; Frederique Gouriet; Alberto Riberi; Jean-Francois Avierinos; Frederic Collart; Olivier Mundler; Didier Raoult; Franck Thuny
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

Review 8.  Pitfalls and Limitations of Radionuclide and Hybrid Imaging in Infection and Inflammation.

Authors:  Andor W J M Glaudemans; Ora Israel; Riemer H J A Slart
Journal:  Semin Nucl Med       Date:  2015-11       Impact factor: 4.446

9.  Improving the Diagnostic Performance of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve Endocarditis.

Authors:  Laurens E Swart; Anna Gomes; Asbjørn M Scholtens; Bhanu Sinha; Wilco Tanis; Marnix G E H Lam; Maureen J van der Vlugt; Sebastian A F Streukens; Erik H J G Aarntzen; Jan Bucerius; Sander van Assen; Chantal P Bleeker-Rovers; Peter Paul van Geel; Gabriel P Krestin; Joost P van Melle; Jolien W Roos-Hesselink; Riemer H J A Slart; Andor W J M Glaudemans; Ricardo P J Budde
Journal:  Circulation       Date:  2018-10-02       Impact factor: 29.690

10.  Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [18F]FDG PET/CTA: "normality" is a possible diagnosis.

Authors:  Albert Roque; María N Pizzi; Nuria Fernández-Hidalgo; Eduard Permanyer; Hug Cuellar-Calabria; Guillermo Romero-Farina; Remedios Ríos; Benito Almirante; Joan Castell-Conesa; Manuel Escobar; Ignacio Ferreira-González; Pilar Tornos; Santiago Aguadé-Bruix
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-01-01       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.